KIRSKE DAVID

CIK 00012767502 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001276750

Recent Transactions

50 trades

Award
X4 Pharmaceuticals, Inc$XFOR
Stock Option (right to buy)
2025-10-29+1,552,769→ 1,552,769 total
Award
X4 Pharmaceuticals, Inc$XFOR
Stock Option (right to buy)
2025-08-14+352,800→ 352,800 total
Award
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2025-08-14+193,254→ 193,254 total
Award
X4 Pharmaceuticals, Inc$XFOR
Stock Option (right to buy)
2025-08-12+1,073,249→ 1,073,249 total
Disposition to Issuer
CTI BIOPHARMA CORP
Stock Option (Right to Buy)
2023-06-26−270,216→ 0 total
Disposition to Issuer
CTI BIOPHARMA CORP
Stock Option (Right to Buy)
2023-06-26−25,000→ 0 total
Disposition to Issuer
CTI BIOPHARMA CORP
Stock Option (Right to Buy)
2023-06-26−200,000→ 0 total
Disposition to Issuer
CTI BIOPHARMA CORP
Stock Option (Right to Buy)
2023-06-26−280,000→ 0 total
Disposition to Issuer
CTI BIOPHARMA CORP
Stock Option (Right to Buy)
2023-06-26−150,000→ 0 total
Disposition from Tender
CTI BIOPHARMA CORP
Common Stock
2023-06-26$9.10/sh−17,547→ 0 total
Disposition to Issuer
CTI BIOPHARMA CORP
Stock Option (Right to Buy)
2023-06-26−83,396→ 0 total
Disposition to Issuer
CTI BIOPHARMA CORP
Stock Option (Right to Buy)
2023-06-26−315,000→ 0 total
Disposition to Issuer
CTI BIOPHARMA CORP
Stock Option (Right to Buy)
2023-06-26−340,000→ 0 total
Award
CTI BIOPHARMA CORP
Stock Option (right to buy)
2023-03-14+200,000→ 200,000 total
Exercise/Conversion
CTI BIOPHARMA CORP
common stock
2023-01-03$0.95/sh+27,021→ 44,148 total
Exercise/Conversion
CTI BIOPHARMA CORP
Non-Qualified Stock Option (right to buy)
2023-01-03−27,021→ 270,216 total
Sale
CTI BIOPHARMA CORP
common stock
2023-01-03$6.01/sh−27,021→ 17,127 total
Exercise/Conversion
CTI BIOPHARMA CORP
Non-Qualified Stock Option (right to buy)
2022-12-30−800→ 298,284 total
Exercise/Conversion
CTI BIOPHARMA CORP
common stock
2022-12-30$0.95/sh+800→ 17,927 total
Sale
CTI BIOPHARMA CORP
common stock
2022-12-30$6.00/sh−800→ 17,127 total
Sale
CTI BIOPHARMA CORP
common stock
2022-12-30$6.01/sh−1,047→ 17,127 total
Sale
CTI BIOPHARMA CORP
common stock
2022-12-30$6.00/sh−12,000→ 17,127 total
Award
CTI BIOPHARMA CORP
common stock
2022-12-30$5.11/sh+214→ 17,127 total
Exercise/Conversion
CTI BIOPHARMA CORP
common stock
2022-12-30$0.95/sh+12,000→ 29,127 total
Exercise/Conversion
CTI BIOPHARMA CORP
Non-Qualified Stock Option (right to buy)
2022-12-30−1,047→ 297,237 total
Exercise/Conversion
CTI BIOPHARMA CORP
common stock
2022-12-30$0.95/sh+1,047→ 18,174 total
Exercise/Conversion
CTI BIOPHARMA CORP
Non-Qualified Stock Option (right to buy)
2022-12-30−12,000→ 299,084 total
Exercise/Conversion
CTI BIOPHARMA CORP
Non-Qualified Stock Option (right to buy)
2022-12-29−13,174→ 311,084 total
Sale
CTI BIOPHARMA CORP
common stock
2022-12-29$6.00/sh−13,174→ 16,913 total
Exercise/Conversion
CTI BIOPHARMA CORP
common stock
2022-12-29$0.95/sh+13,174→ 30,087 total
Exercise/Conversion
CTI BIOPHARMA CORP
common stock
2022-10-04$0.95/sh+100→ 17,013 total
Sale
CTI BIOPHARMA CORP
common stock
2022-10-04$6.27/sh−609→ 16,913 total
Exercise/Conversion
CTI BIOPHARMA CORP
Non-Qualified Stock Option (right to buy)
2022-10-04−1,400→ 324,967 total
Exercise/Conversion
CTI BIOPHARMA CORP
common stock
2022-10-04$0.95/sh+1,400→ 18,313 total
Sale
CTI BIOPHARMA CORP
common stock
2022-10-04$6.26/sh−100→ 16,913 total
Sale
CTI BIOPHARMA CORP
common stock
2022-10-04$6.25/sh−1,400→ 16,913 total
Exercise/Conversion
CTI BIOPHARMA CORP
common stock
2022-10-04$0.95/sh+609→ 17,522 total
Exercise/Conversion
CTI BIOPHARMA CORP
Non-Qualified Stock Option (right to buy)
2022-10-04−100→ 324,867 total
Exercise/Conversion
CTI BIOPHARMA CORP
Non-Qualified Stock Option (right to buy)
2022-10-04−609→ 324,258 total
Sale
CTI BIOPHARMA CORP
common stock
2022-10-03$6.25/sh−300→ 16,913 total
Exercise/Conversion
CTI BIOPHARMA CORP
Non-Qualified Stock Option (right to buy)
2022-10-03−300→ 326,367 total
Exercise/Conversion
CTI BIOPHARMA CORP
common stock
2022-10-03$0.95/sh+300→ 17,213 total
Exercise/Conversion
CTI BIOPHARMA CORP
common stock
2022-09-30$0.95/sh+139,841→ 156,754 total
Exercise/Conversion
CTI BIOPHARMA CORP
Non-Qualified Stock Option (right to buy)
2022-09-30−139,841→ 326,667 total
Sale
CTI BIOPHARMA CORP
common stock
2022-09-30$6.05/sh−139,841→ 16,913 total
Exercise/Conversion
CTI BIOPHARMA CORP
Non-Qualified Stock Option (right to buy)
2022-09-29−100→ 466,508 total
Sale
CTI BIOPHARMA CORP
common stock
2022-09-29$6.01/sh−100→ 16,913 total
Exercise/Conversion
CTI BIOPHARMA CORP
common stock
2022-09-29$0.95/sh+800→ 17,713 total
Exercise/Conversion
CTI BIOPHARMA CORP
common stock
2022-09-29$0.95/sh+100→ 17,013 total
Exercise/Conversion
CTI BIOPHARMA CORP
Non-Qualified Stock Option (right to buy)
2022-09-29−800→ 466,608 total

Companies

Recent Filings

Address

C/O X4 PHARMACEUTICALS INC. 61 N BEACON STREET, 4TH FLOOR

BOSTON, MA, 02134

View on SEC.gov